(S)-(TETRAHYDROFURAN-3-YL)METHANAMINE HCL, 95.0%, 250mg

(3R,4R)-3-Fluorotetrahydro-2H-pyran-4-amine hydrochloride, 98%, 500mg

Methyl 4-aminoisothiazole-3-carboxylate, 95%, 1g

Vinylene Carbonate (stabilized with BHT)>98.0%(GC)5g

Azur II, for microscopy, 50 g, glass packaging

Ethyl 7-bromo-4-oxo-1,4-dihydro-1,5-naphthyridine-3-carboxylate, 95.0%, 1g

OXANE-4-CARBOXIMIDAMIDE, 95.0%, 1g

(1S,2S)-N1-(tert-Butoxycarbonyl)-1,2-cyclohexanediamine>98.0%(GC)(T)1g

(5-(Hydroxymethyl)pyridin-3-yl)boronic acid, 95.0%, 100mg

4-Methyl-2-hexylamine Hydrochloride>98.0%(T)1g

ROTI®Cell Hanks BSS

ethyl 5-amino-1-(3,4-dichlorophenyl)-1H-pyrazole-3-carboxylate, 95.0%, 2g

N-Cyclohexylformamide, 98+%, 100g